Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.

The New England journal of medicine ·Vol. 324 ·No. 3 ·1991-01-17 ·Pages 200

Wahl RL, Cody R, Hutchins G, Mudgett E

Abstract

暂无摘要

MeSH Terms

Breast Neoplasms/diagnostic imaging Deoxyglucose/analogs & derivatives Female Fluorine Radioisotopes Fluorodeoxyglucose F18 Humans Middle Aged Neoplasm Metastasis Tomography, Emission-Computed

Chemicals

Fluorine Radioisotopes Fluorodeoxyglucose F18 Deoxyglucose

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Wahl R L

Cody R

Hutchins G

Mudgett E

Article Info

Journal

The New England journal of medicine

Abbr.

N Engl J Med

ISSN

0028-4793

DOI

10.1056/NEJM199101173240317

Published

1991-01-17

Pages

200

Language

English

Region

United States

NLM ID

0255562

Subset

External Links

PubMed source DOI: 10.1056/NEJM199101173240317 View journal details

Analysis Services

Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.

Contact

WeChat Official Account